100
Participants
Start Date
May 23, 2022
Primary Completion Date
June 14, 2024
Study Completion Date
September 19, 2024
AVTR101
three times daily
Placebo
three times daily
Seoul National University Bundang Hospital, Seongnam-si
Ajou University School of Medicine, Suwon
Asan Medical Center, Seoul
SMG-SNU Boramae Medical Center, Seoul
Lead Sponsor
Collaborators (1)
Seoul National University Bundang Hospital
OTHER
Ajou University School of Medicine
OTHER
SMG-SNU Boramae Medical Center
OTHER
Asan Medical Center
OTHER
Aventi Biotechnology Inc.
INDUSTRY